Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
367-05-003 ISMRM Abstract

Towards Harmonisation of Paramagnetic Rim Lesion Detection in Multiple Sclerosis: Comparing T2*-Weighted and QSM imaging

Primary: Neuro - Multiple Sclerosis
Secondary: Contrast Mechanisms - Susceptibility/QSM
367-05-003 · Neuroinflammation: Myelin and Iron · Monday, 11 May, 4:10 PM–5:05 PM · Digital Posters Row H
Keywords: Multiple Sclerosis T2-weighted imaging Quantitative Susceptibility Mapping (QSM) Paramagneric rim lesions Clinical Translation
Accepted
Francesca Pentimalli Biscaretti di Ruffia 1, Rozanna Meijboom1,2,3, Peter Foley3, Samantha Hendry1, Michael J Thrippleton1,2, Daisy Mollison3, Pascal Sati4, Niall MacDougall3,5, Siddharthan Chandran1,3, Elizabeth N York1,2,3, Patrick Kearns1,3, David P. Hunt1,3, Adam D Waldman1,2,3
1Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom
2Edinburgh Imaging, University of Edinburgh, Edinburgh, United Kingdom
3Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom
4edars-Sinai Department of Neurology and Biomedical Imaging Research Institute, Los Angeles, California, United States of America
5Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom
Presenting Author: Francesca Pentimalli Biscaretti di Ruffia

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Multiple Sclerosis International Federation (MSIF). Atlas of MS 2020: Mapping Multiple Sclerosis Around the World. London, UK: MSIF; 2020. Available at: https://www.msif.org/wp-content/uploads/2020/11/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-November-2020.pdf
2. Barker-Collo S, Feigin VL. Immunology of relapse and remission in multiple sclerosis. Annu Rev Immunol. 2014;32:257–281. doi:10.1146/annurev-immunol-032713-120227 [doi]
3. Giovannoni G, Popescu V, Wuerfel J, et al. Smouldering multiple sclerosis: the ‘real MS’. Ther Adv Neurol Disord. 2022;15:17562864211010223. doi:10.1177/17562864211010223 [doi]
4. Ng Kee Kwong KC, Mollison D, Meijboom R, et al. Rim lesions are demonstrated in early relapsing–remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional setting. Neuroradiology. 2022;64(1):109–117. doi:10.1007/s00234-021-02768-x [doi]
5. Montalban X, Lebrun-Frénay C, Oh J, Arrambide G, Moccia M, Amato MP, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850–865. doi:10.1016/S1474-4422(25)00150-3 [doi]
6. Bagnato F, Sati P, Hemond CC, et al. Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain. 2024;147(3):828–849. doi:10.1093/brain/awae013 [doi]
7. Li J, Chang S, Liu T, et al. Reducing the object orientation dependence of susceptibility effects in gradient-echo MRI through quantitative susceptibility mapping. Magn Reson Med. 2012;68(5):1563–1569. doi:10.1002/mrm.24135 [doi]
8. Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2014;73(1):82–101. doi:10.1002/mrm.25358 [doi]
9. QSM Consensus Organization Committee, Bilgic B, Costagli M, Chan KS, et al. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: a consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group. Magn Reson Med. 2024;91(1):142–157. doi:10.1002/mrm.30006 [doi]
10. Kearns PKA, Martin SJ, Chang J, et al. FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing–remitting multiple sclerosis. BMJ Open. 2022;12(6):e058506. doi:10.1136/bmjopen-2021-058506 [doi]
11. Meijboom R, Wiseman SJ, York EN, et al. Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing–remitting multiple sclerosis in Scotland. Wellcome Open Res. 2022;7:94. doi:10.12688/wellcomeopenres.17731.1 [doi]
12. Stewart AW, Robinson SD, O’Brien K, et al. QSMxT: robust masking and artefact reduction for quantitative susceptibility mapping. Magn Reson Med. 2022;87(3):1289–1300. doi:10.1002/mrm.29048 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/367-05-003